The consistent overexpression of INTS13 in cervical cancer tissues, its correlation with advanced disease and poorer survival, and its functional validation in vitro and in vivo underscore its potential as a valuable therapeutic target. The gene discussed is INTS13; the disease is cervical carcinoma.